Financhill
Back

Arcellx Vs. Blueprint Medicines Industry Stock Comparison

Sell
23

ACLX
Arcellx

Last Price:
$65.27
Seasonality Move:
-11.15%
Sell
24

BPMC
Blueprint Medicines

Last Price:
$93.91
Seasonality Move:
5.74%
Sell
23
Arcellx (ACLX) is a Sell

Is Arcellx a Buy, Sell or Hold?

  • The current Arcellx [ACLX] share price is $65.23. The Score for ACLX is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • ACLX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
24
Blueprint Medicines (BPMC) is a Sell

Is Blueprint Medicines a Buy, Sell or Hold?

  • The current Blueprint Medicines [BPMC] share price is $93.94. The Score for BPMC is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
  • BPMC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ACLX Stock Price Chart

What is Arcellx's stock price today?

  • The Arcellx share price today is $65.23
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ACLX is experiencing slight buying pressure.

BPMC Stock Price Chart

What is Blueprint Medicines's stock price today?

  • The Blueprint Medicines share price today is $93.94
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BPMC is experiencing slight selling pressure.

ACLX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.23 Sell
Relative Strength Index (14 RSI): 42.67 Sell
Chaikin Money Flow: 160150 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (64.09 - 67.83) Sell
Bollinger Bands (100): (70.19 - 91.11) Sell

BPMC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.47 Sell
Relative Strength Index (14 RSI): 34.2 Sell
Chaikin Money Flow: -344768 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (100.13 - 114.53) Sell
Bollinger Bands (100): (86.8 - 104.06) Sell

ACLX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 65.77 Sell
20-day SMA: 65.67 Sell
50-day SMA: 73.1 Sell
200-day SMA: 70.22 Sell
8-day EMA: 65.16 Buy
20-day EMA: 66.73 Sell
50-day EMA: 71.81 Sell
200-day EMA: 70.96 Sell

BPMC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 102.9 Sell
20-day SMA: 109.05 Sell
50-day SMA: 99.72 Sell
200-day SMA: 98.82 Sell
8-day EMA: 101.64 Sell
20-day EMA: 104.41 Sell
50-day EMA: 101.45 Sell
200-day EMA: 95.01 Sell

Arcellx Earnings Growth & ACLX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.73 per share, and a decrease next year of $0.69 per share.

Blueprint Medicines Earnings Growth & BPMC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.69 per share, an increase next quarter of $0.00 per share, an increase this year of $0.09 per share, and an increase next year of $2.69 per share.

Arcellx Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Blueprint Medicines Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):